acase@tulane.edu / Peptides and peptide nucleic acids (PNAs) have long been recognized as promising tools and potential therapeutics. Yet the cell membrane remains a significant barrier to their intracellular targets. Conjugation to cell penetrating peptides like pTat48-60 (tat) and pAntp43-68 (penetratin) facilitates delivery, however delivery efficiencies remain low. Improving the performance of known cell penetrating peptides by rational design is hindered by the lack of explicit design principles. Instead, here we use synthetic molecular evolution to generate and screen a cell penetrating peptide library containing 8,192 tat/penetratin hybrid peptides to identify sequences with improved ability to deliver a splice correcting PNA sequence. The parent sequences poorly deliver PNA to cells; however, at 5M peptide-PNA, the top performing PNA conjugated Delivery Peptide (PDEP) daughter sequence showed an 80-fold increase over PNA only treated cells in properly spliced luciferase mRNA and 33-fold higher standardized luminescence values than the top performing parent sequence penetratin. The PDEPs identified in this study are effective in multiple cell types, and also deliver a peptide cargo to cells. The capabilities of the PDEPs make them a valuable research tool for delivery of membrane impermeable PNA or peptide sequences. This dramatic improvement in performance following a single iteration of synthetic molecular evolution is an indication of the power of this approach to peptide sequence optimization. / 1 / William Berkeley Kauffman
| Identifer | oai:union.ndltd.org:TULANE/oai:http://digitallibrary.tulane.edu/:tulane_77216 |
| Date | January 2017 |
| Contributors | Kauffman, W. Berkeley (author), (author), Wimley, William (Thesis advisor), (Thesis advisor), School of Medicine Biomedical Sciences Graduate Program (Degree granting institution) |
| Publisher | Tulane University |
| Source Sets | Tulane University |
| Language | English |
| Detected Language | English |
| Type | Text |
| Format | electronic, 132 |
| Rights | No embargo, Copyright is in accordance with U.S. Copyright law. |
Page generated in 0.0031 seconds